Cerebrovascular Disease Peripheral Arterial Disease Quality of Life 
DAIC
JULY 29, 2024
mtaschetta-millane Mon, 07/29/2024 - 09:16 July 29, 2024 — CorVascular , a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD) testing devices, today announced the U.S. Food and Drug Administration (FDA) has cleared its VasoGuard V-Series as Class II medical devices.
Frontiers in Cardiovascular Medicine
MARCH 6, 2024
Patients underwent a comprehensive angiological screening, which included blood serum analysis, assessment of medical and family history, cardiovascular risk, and disease status, and evaluation of lifestyle and quality of life. 3.95, p = 0.003). 3.95, p = 0.003). vs. 45.8%; 17.6% vs. 13.9%, p = 0.001).
Expert insights. Personalized for you.
108 
Let's personalize your content